SGK2 Human (2,4,5-trichlorophenoxy)acetic acid increases expression ISO Sgk2 (Mus musculus) 6480464 2 more ... CTD PMID:18579281 SGK2 Human 1,1-dichloroethene decreases expression ISO Sgk2 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SGK2 mRNA CTD PMID:26682919 SGK2 Human 1,2-dimethylhydrazine decreases expression ISO Sgk2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SGK2 mRNA CTD PMID:22206623 SGK2 Human 17alpha-ethynylestradiol multiple interactions ISO Sgk2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SGK2 mRNA CTD PMID:17942748 SGK2 Human 17beta-estradiol decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of SGK2 mRNA CTD PMID:32145629 SGK2 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Sgk2 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SGK2 mRNA CTD PMID:17942748 SGK2 Human 2,4,6-trinitrotoluene affects expression ISO Sgk2 (Rattus norvegicus) 6480464 Trinitrotoluene affects the expression of SGK2 mRNA CTD PMID:21346803 SGK2 Human 2-amino-4,6-dinitrotoluene affects expression ISO Sgk2 (Rattus norvegicus) 6480464 2-amino-4 and 6-dinitrotoluene affects the expression of SGK2 mRNA CTD PMID:21346803 SGK2 Human 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 3 more ... CTD PMID:20959002 SGK2 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Sgk2 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of SGK2 mRNA CTD PMID:25172293 SGK2 Human 4-hydroxyphenyl retinamide increases expression ISO Sgk2 (Mus musculus) 6480464 Fenretinide results in increased expression of SGK2 mRNA CTD PMID:28973697 SGK2 Human 6-propyl-2-thiouracil decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SGK2 mRNA CTD PMID:24780913 SGK2 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of SGK2 protein CTD PMID:20106945 SGK2 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SGK2 mRNA CTD PMID:21641981 SGK2 Human aldehydo-D-glucose multiple interactions EXP 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 SGK2 Human ammonium chloride affects expression ISO Sgk2 (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of SGK2 mRNA CTD PMID:16483693 SGK2 Human ampicillin decreases expression EXP 6480464 Ampicillin results in decreased expression of SGK2 mRNA CTD PMID:21632981 SGK2 Human aristolochic acid A increases expression EXP 6480464 aristolochic acid I results in increased expression of SGK2 mRNA CTD PMID:33212167 SGK2 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of SGK2 gene CTD PMID:25304211 SGK2 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of SGK2 gene CTD PMID:25304211 SGK2 Human atorvastatin calcium multiple interactions EXP 6480464 [Atorvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA CTD PMID:24204015 SGK2 Human azoxystrobin affects expression EXP 6480464 azoxystrobin affects the expression of SGK2 mRNA CTD PMID:33512557 SGK2 Human barium(0) multiple interactions EXP 6480464 Barium inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 SGK2 Human benzo[a]pyrene increases expression ISO Sgk2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SGK2 mRNA CTD PMID:19770486 and PMID:27195522 SGK2 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SGK2 mRNA CTD PMID:32234424 SGK2 Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of SGK2 3' UTR and Benzo(a)pyrene results in increased methylation of SGK2 5' UTR CTD PMID:27901495 SGK2 Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of SGK2 promoter CTD PMID:27901495 SGK2 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SGK2 mRNA CTD PMID:20106945 more ... SGK2 Human Benzo[ghi]perylene increases expression ISO Sgk2 (Mus musculus) 6480464 1 and 12-benzoperylene results in increased expression of SGK2 mRNA CTD PMID:26377693 SGK2 Human beta-naphthoflavone multiple interactions ISO Sgk2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SGK2 mRNA CTD PMID:18164116 SGK2 Human beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of SGK2 mRNA CTD PMID:19737606 SGK2 Human bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of SGK2 mRNA CTD PMID:31163220 SGK2 Human bisphenol A decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of SGK2 mRNA CTD PMID:25181051 and PMID:32145629 SGK2 Human bromobenzene decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 bromobenzene results in decreased expression of SGK2 mRNA CTD PMID:32479839 SGK2 Human buta-1,3-diene decreases expression ISO Sgk2 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SGK2 mRNA CTD PMID:29038090 SGK2 Human captan increases expression ISO Sgk2 (Mus musculus) 6480464 Captan results in increased expression of SGK2 mRNA CTD PMID:31558096 SGK2 Human carbon nanotube decreases expression ISO Sgk2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 SGK2 Human carbon nanotube increases expression ISO Sgk2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 SGK2 Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to SGK2 gene] CTD PMID:28238834 SGK2 Human chlorpyrifos increases expression ISO Sgk2 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SGK2 mRNA CTD PMID:37019170 SGK2 Human chromium(6+) affects expression ISO Sgk2 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SGK2 mRNA CTD PMID:28472532 SGK2 Human cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SGK2 mRNA CTD PMID:27392435 SGK2 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SGK2 mRNA CTD PMID:27392435 SGK2 Human clofibrate increases expression ISO Sgk2 (Mus musculus) 6480464 Clofibrate results in increased expression of SGK2 mRNA CTD PMID:23811191 SGK2 Human clothianidin decreases expression EXP 6480464 clothianidin results in decreased expression of SGK2 mRNA CTD PMID:29044138 SGK2 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of SGK2 mRNA CTD PMID:19549813 SGK2 Human copper(II) sulfate increases expression ISO Sgk2 (Mus musculus) 6480464 Copper Sulfate results in increased expression of SGK2 mRNA CTD PMID:18579281 SGK2 Human Cuprizon decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of SGK2 mRNA CTD PMID:26577399 and PMID:27523638 SGK2 Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of SGK2 mRNA CTD PMID:20106945 SGK2 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SGK2 mRNA CTD PMID:27989131 SGK2 Human D-glucose multiple interactions EXP 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 SGK2 Human dextran sulfate multiple interactions ISO Sgk2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SGK2 mRNA CTD PMID:29950665 SGK2 Human dichloroacetic acid increases expression ISO Sgk2 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of SGK2 mRNA CTD PMID:28962523 SGK2 Human diclofenac decreases expression ISO Sgk2 (Mus musculus) 6480464 Diclofenac results in decreased expression of SGK2 mRNA CTD PMID:26934552 SGK2 Human dicrotophos increases expression EXP 6480464 dicrotophos results in increased expression of SGK2 mRNA CTD PMID:28302478 SGK2 Human dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of SGK2 mRNA CTD PMID:26516004 SGK2 Human diquat increases expression ISO Sgk2 (Mus musculus) 6480464 Diquat results in increased expression of SGK2 protein CTD PMID:36851058 SGK2 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 SGK2 Human doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of SGK2 mRNA CTD PMID:37062353 SGK2 Human endosulfan increases expression ISO Sgk2 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SGK2 mRNA CTD PMID:29391264 SGK2 Human fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SGK2 mRNA CTD PMID:25572481 SGK2 Human fluvastatin multiple interactions EXP 6480464 [fluvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA CTD PMID:24204015 SGK2 Human glucose multiple interactions EXP 6480464 SGK2 mutant form inhibits the reaction [[Simvastatin co-treated with NR1I2 protein] results in increased secretion of Glucose] CTD PMID:24204015 SGK2 Human glutathione increases expression ISO Sgk2 (Rattus norvegicus) 6480464 Glutathione deficiency results in increased expression of SGK2 mRNA CTD PMID:20621112 SGK2 Human GW 4064 increases expression ISO Sgk2 (Mus musculus) 6480464 GW 4064 results in increased expression of SGK2 mRNA CTD PMID:26655953 SGK2 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of SGK2 mRNA CTD PMID:23410634 SGK2 Human isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of SGK2 mRNA CTD PMID:20436886 SGK2 Human Licochalcone B increases expression EXP 6480464 licochalcone B results in increased expression of SGK2 mRNA CTD PMID:33647349 SGK2 Human menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of SGK2 mRNA CTD PMID:23410634 SGK2 Human metformin increases expression ISO Sgk2 (Rattus norvegicus) 6480464 Metformin results in increased expression of SGK2 mRNA CTD PMID:31324951 SGK2 Human methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of SGK2 mRNA CTD PMID:29581082 SGK2 Human N-methylformamide increases expression ISO Sgk2 (Mus musculus) 6480464 methylformamide analog results in increased expression of SGK2 mRNA and methylformamide results in increased expression of SGK2 mRNA CTD PMID:17040096 SGK2 Human N-nitrosodiethylamine multiple interactions ISO Sgk2 (Rattus norvegicus) 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of SGK2 mRNA CTD PMID:18164116 SGK2 Human nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of SGK2 mRNA CTD PMID:24768652 and PMID:25583101 SGK2 Human ouabain multiple interactions EXP 6480464 Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 SGK2 Human paracetamol affects expression ISO Sgk2 (Mus musculus) 6480464 Acetaminophen affects the expression of SGK2 mRNA CTD PMID:17562736 SGK2 Human paracetamol decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of SGK2 mRNA CTD PMID:32479839 SGK2 Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SGK2 mRNA CTD PMID:21420995 and PMID:29067470 SGK2 Human paraquat increases expression ISO Sgk2 (Rattus norvegicus) 6480464 Paraquat results in increased expression of SGK2 mRNA CTD PMID:32680482 SGK2 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SGK2 mRNA CTD PMID:35182771 SGK2 Human PCB138 decreases expression ISO Sgk2 (Rattus norvegicus) 6480464 2 more ... CTD PMID:23829299 SGK2 Human perfluorohexanesulfonic acid decreases expression ISO Sgk2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of SGK2 mRNA CTD PMID:37995155 SGK2 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SGK2 mRNA CTD PMID:19084549 SGK2 Human picoxystrobin decreases expression EXP 6480464 picoxystrobin results in decreased expression of SGK2 mRNA CTD PMID:33512557 SGK2 Human pirinixic acid increases expression ISO Sgk2 (Mus musculus) 6480464 pirinixic acid results in increased expression of SGK2 mRNA CTD PMID:17426115 more ... SGK2 Human potassium atom multiple interactions EXP 6480464 Barium inhibits the reaction [SGK2 protein results in increased transport of Potassium] and Ouabain inhibits the reaction [SGK2 protein results in increased transport of Potassium] CTD PMID:12590200 SGK2 Human potassium atom increases transport EXP 6480464 SGK2 protein results in increased transport of Potassium CTD PMID:12590200 SGK2 Human pregnenolone 16alpha-carbonitrile decreases expression ISO Sgk2 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SGK2 mRNA CTD PMID:28903501 SGK2 Human propiconazole decreases expression ISO Sgk2 (Mus musculus) 6480464 propiconazole results in decreased expression of SGK2 mRNA CTD PMID:21278054 SGK2 Human quinolin-8-ol decreases expression EXP 6480464 Oxyquinoline results in decreased expression of SGK2 mRNA CTD PMID:21632981 SGK2 Human rifampicin increases expression EXP 6480464 Rifampin results in increased expression of SGK2 mRNA CTD PMID:24204015 SGK2 Human rifampicin multiple interactions EXP 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA more ... CTD PMID:21127053 and PMID:24204015 SGK2 Human rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SGK2 mRNA CTD PMID:33512557 SGK2 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 SGK2 Human silicon dioxide affects expression EXP 6480464 Silicon Dioxide analog affects the expression of SGK2 mRNA CTD PMID:25895662 SGK2 Human simvastatin multiple interactions EXP 6480464 [Simvastatin co-treated with NR1I2 protein] results in increased expression of SGK2 mRNA more ... CTD PMID:24204015 SGK2 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SGK2 mRNA CTD PMID:29301061 SGK2 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SGK2 mRNA CTD PMID:34032870 SGK2 Human streptozocin increases expression ISO Sgk2 (Mus musculus) 6480464 Streptozocin results in increased expression of SGK2 mRNA CTD PMID:16116964 SGK2 Human tert-butyl hydroperoxide affects expression EXP 6480464 tert-Butylhydroperoxide affects the expression of SGK2 mRNA CTD PMID:23410634 SGK2 Human tetrachloroethene increases expression ISO Sgk2 (Mus musculus) 6480464 Tetrachloroethylene results in increased expression of SGK2 mRNA CTD PMID:28973375 SGK2 Human tetrachloromethane decreases expression ISO Sgk2 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SGK2 mRNA CTD PMID:31919559 SGK2 Human titanium dioxide multiple interactions ISO Sgk2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SGK2 mRNA CTD PMID:29950665 SGK2 Human tremolite asbestos increases expression ISO Sgk2 (Mus musculus) 6480464 tremolite results in increased expression of SGK2 mRNA CTD PMID:29279043 SGK2 Human troglitazone increases expression ISO Sgk2 (Rattus norvegicus) 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:21515302 SGK2 Human troglitazone increases expression EXP 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:25572481 SGK2 Human troglitazone increases expression ISO Sgk2 (Mus musculus) 6480464 troglitazone results in increased expression of SGK2 mRNA CTD PMID:28973697 SGK2 Human urethane decreases expression EXP 6480464 Urethane results in decreased expression of SGK2 mRNA CTD PMID:28818685 SGK2 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SGK2 mRNA CTD PMID:29154799 SGK2 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SGK2 mRNA CTD PMID:27188386 SGK2 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SGK2 mRNA CTD PMID:24383497 and PMID:26272509 SGK2 Human vancomycin increases expression ISO Sgk2 (Mus musculus) 6480464 Vancomycin results in increased expression of SGK2 mRNA CTD PMID:18930951
